The World Health Organization (WHO) has published this year a first list of antibiotic-resistant “priority pathogens,” which includes 12 families of bacteria that are most dangerous to human health.
The list was drawn up in a bid to guide and promote research and development (R&D) of new antibiotics, as part of WHO’s efforts to address growing global resistance to antimicrobial medicines. Is divided into three categories according to the urgency of need for new antibiotics: critical, high and medium priority. The list is intended to spur governments to put in place policies that incentivize basic science and advanced R&D by both publicly funded agencies and the private sector investing in new antibiotic discovery.
Among the critical priority group are multi-resistant bacteria such as Acinetobacter baumanii, Pseudomonas aeruginosa and enterobacteriaceae such as Klebsiella pneumoniae, E. coli, Serratia, and Proteus. These bacteria can cause serious and often lethal infections. The list highlights in particular the threat of gram-negative bacteria that are resistant to multiple antibiotics. These bacteria have built-in abilities to find new ways to resist treatment and can pass along genetic material that allows other bacteria to become drug-resistant as well.
To combat these multidrug-resistant pathogens, in addition to proper use of antibiotics, effective infection control is paramount. To meet this need, Terragene offers a wide range of innovative products that pose a great challenge to disinfection and sterilization processes, giving peace of mind to healthcare institutions and contributing to quality assurance in the food, pharmaceutical and medical devices industry.